U.S. RESEARCH ROUNDUP-Elf Beauty, PTC Therapeutics, Shoals Technologies Group

Core Laboratories

06/10/2023 07:49

Oct 6 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Elf Beauty, PTC Therapeutics, and Shoals
Technologies Group on Friday. 
     
    HIGHLIGHTS
                 * Elf Beauty Inc  ELF.N : Jefferies raises to buy from hold
 
                 * PTC Therapeutics Inc  PTCT.O : Truist Securities cuts to hold from buy 
 
                 * Shoals Technologies Group Inc  SHLS.O : Piper Sandler raises to overweight from neutral 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order. 
    
                 * Align Technology Inc  ALGN.O : Baird cuts target price to $375 from $405 
 
                 * Ameresco Inc  AMRC.N : Piper Sandler cuts target price to $59 from $64 
 
                 * AngioDynamics Inc  ANGO.O : Raymond James cuts target price to $12 from $13 
 
                 * Apellis Pharmaceuticals Inc  APLS.O : Raymond James raises target price to $92 from $89 
 
                 * Block Inc  SQ.N : TD Cowen initiates coverage with outperform rating and $59 target price 
 
                 * Championx Corp  CHX.O : TD Cowen raises target price to $41 from $40 
 
                 * Conagra Brands Inc  CAG.N : CFRA cuts target price by $5 to $30 
 
                 * Conagra Brands Inc  CAG.N : Jefferies cuts target price to $28 from $30 
 
                 * Conagra Brands Inc  CAG.N : RBC cuts target price to $32 from $36 
 
                 * Conagra Brands Inc  CAG.N : TD Cowen cuts target price to $29 from $32 
 
                 * Core Laboratories Inc  CLB.N : TD Cowen cuts target price to $18 from $19 
 
                 * Cullinan Oncology Inc  CGEM.O : Jonestrading initiates coverage with buy rating; PT $22 
 
                 * Dell Technologies Inc  DELL.N : Goldman Sachs raises target price to $78 
 
                 * Dril-Quip Inc  DRQ.N : TD Cowen cuts target price to $25 from $26 
 
                 * Duos Technologies Group Inc  DUOT.O : Ascendiant Capital Markets cuts PT to $8.25 from $8.5 
 
                 * Elf Beauty Inc  ELF.N : Jefferies raises to buy from hold
 
                 * Elf Beauty Inc  ELF.N : Jefferies raises target price to $115 from $110 
 
                 * Envista Holdings Corp  NVST.N : Baird cuts target price to $33 from $38 
 
                 * Equitable Holdings Inc  EQH.N : JP Morgan cuts target price to $35 from $36 
 
                 * First Solar Inc  FSLR.O : Piper Sandler cuts target price to $235 from $240 
 
                 * Fis  FIS.N : TD Cowen initiates coverage with market perform rating and $56 target price 
 
                 * Fiserv Inc  FI.N : TD Cowen initiates coverage with outperform rating and $136 target price 
 
                 * Fluence Energy Inc  FLNC.O : Piper Sandler cuts target price to $22 from $24 
 
                 * FTC Solar Inc  FTCI.O : Piper Sandler cuts target price to $1.5 from $2.5 
 
                 * Global Payments Inc  GPN.N : TD Cowen initiates coverage with outperform rating 
 
                 * Global Payments Inc  GPN.N : TD Cowen initiates coverage with $150 target price 
 
                 * Globe Life Inc  GL.N : JP Morgan raises target price to $132 from $131 
 
                 * Halliburton Co  HAL.N : TD Cowen raises target price to $47 from $44 
 
                 * Helmerich and Payne Inc  HP.N : TD Cowen raises target price to $42 from $41 
 
                 * Itron Inc  ITRI.O : Piper Sandler raises target price to $71 from $63 
 
                 * Lamb Weston Holdings Inc  LW.N : JP Morgan cuts target price to $127 from $129 
 
                 * Liberty Energy Inc  LBRT.N : TD Cowen raises target price to $18 from $14 
 
                 * Materion Corp  MTRN.N : KeyBanc cuts target price to $128 from $133 
 
                 * Metlife Inc  MET.N : JP Morgan cuts target price to $82 from $85 
 
                 * Neurocrine Biosciences Inc  NBIX.O : Leerink Partners raises target price to $135 from $125 
 
                 * Neurocrine Biosciences Inc  NBIX.O : Oppenheimer raises target price to $165 from $160 
 
                 * Oceaneering International Inc  OII.N : TD Cowen raises target price to $23 from $21 
 
                 * Par Technology Corp  PAR.N : Jefferies raises target price to $45 from $35 
 
                 * PayPal Holdings Inc  PYPL.O : TD Cowen initiates coverage with market perform rating 
 
                 * PayPal Holdings Inc  PYPL.O : TD Cowen initiates coverage with $66 target price 
 
                 * Principal Financial Group Inc  PFG.O : JP Morgan cuts target price to $85 from $87 
 
                 * Prudential Financial Inc  PRU.N : JP Morgan cuts target price to $119 from $121 
 
                 * PTC Therapeutics Inc  PTCT.O : Truist Securities cuts target price to $25 from $45 
 
                 * PTC Therapeutics Inc  PTCT.O : Truist Securities cuts to hold from buy 
 
                 * Rayzebio Inc  RYZB.O : William Blair initiates coverage with outperform rating 
 
                 * Reinsurance Group of America Inc  RGA.N : JP Morgan raises target price to $170 from $168 
 
                 * RPM International Inc  RPM.N : RBC raises target price to $105 from $103 
 
                 * Shoals Technologies Group Inc  SHLS.O : Piper Sandler raises to overweight from neutral 
 
                 * Stem Inc  STEM.N : Piper Sandler cuts target price to $4 from $5 
 
                 * Sutro Biopharma Inc  STRO.O : Oppenheimer initiates coverage with outperform rating
 
                 * Sutro Biopharma Inc  STRO.O : Oppenheimer initiates coverage with target price $10 
 
                 * TPI Composites Inc  TPIC.O : Piper Sandler cuts target price to $3 from $7 
 
                 * Voya Financial Inc  VOYA.N : JP Morgan cuts target price to $89 from $96 
 
                 * Yeti Holdings Inc  YETI.N : KeyBanc cuts target price to $33 from $34 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))